Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
06/1999
06/03/1999CA2311763A1 Method for producing human intervertebral disc cells
06/03/1999CA2311759A1 Recombinant mycoplasma hyopneumoniae vaccine
06/03/1999CA2311736A1 Therapeutic treatment for chronic myeloid leukemia and acute lymphoid leukemia
06/03/1999CA2311733A1 Proliferatively active product for treating proliferating cells
06/03/1999CA2311237A1 Human proteins having transmembrane domains and dnas encoding these proteins
06/03/1999CA2311235A1 Method of mobilizing hematopoietic stem cells
06/03/1999CA2311131A1 Metabotropic glutamate receptor antagonists for treating central nervous system diseases
06/03/1999CA2311129A1 Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scours
06/03/1999CA2310892A1 Chemokine alpha-5
06/03/1999CA2310852A1 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
06/03/1999CA2310775A1 Mucosal delivery system comprising lipophilic thrombin inhibitors
06/03/1999CA2310773A1 Use of substituted 11-phenyl-dibenzazepine compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scour
06/03/1999CA2310565A1 Human protein kinase and kinase inhibitors
06/03/1999CA2310401A1 Alpha-hydroxy, -amino and -halo derivatives of beta-sulfone hydroxamates as matrix metalloproteinase inhibitors
06/03/1999CA2310069A1 Combination of an aldose reductase inhibitor and a glycogen phosphorylase inhibitor
06/03/1999CA2309855A1 Testosterone inhibitors and use for the protection of neurons
06/03/1999CA2309809A1 Histamine and serotonin binding molecules
06/03/1999CA2309341A1 Substituted .beta.-alanine derivatives as cell adhesion inhibitors
06/03/1999CA2309338A1 Cyclic amino acid derivatives as cell adhesion inhibitors
06/03/1999CA2303864A1 Inhibition of lipoprotein oxidation
06/03/1999CA2255318A1 Combination therapy
06/02/1999EP0919622A2 Surface expression of enzyme in gene directed prodrug therapy
06/02/1999EP0919617A1 Anti-human mp52 monoclonal antibody
06/02/1999EP0919563A2 Synthetic Core 2-Like Branched Structures as Ligands for Selectins
06/02/1999EP0919550A1 Pseudopolymorphic forms of 2-2-4-bis(4-fluorophenyl)methyl-1-piperazinyl-ethoxy acetic acid dihydrochloride
06/02/1999EP0919544A1 Compounds useful for treating allergic and inflammatory diseases
06/02/1999EP0919541A1 Naphthalene compounds, process for their preparation and their pharmaceutical compositions
06/02/1999EP0919245A2 NK-1 receptor antagonist and a systemic antiinflammatory corticosteroid for the treatment of emesis
06/02/1999EP0919235A1 Use of a norepinephrine reuptake inhibitor for the treatment of conduct disorder
06/02/1999EP0919234A2 Potentiation of pharmaceuticals by moxonidine
06/02/1999EP0918875A1 Novel internal ribosome entry site and vector containing same
06/02/1999EP0918859A1 Testis-specific insulin homolog polypeptides
06/02/1999EP0918794A2 Uses for wnt polypeptides
06/02/1999EP0918792A1 Dipeptide benzamidine as a kininogenase inhibitor
06/02/1999EP0918777A1 SELECTED DERIVATIVES OF K-252a
06/02/1999EP0918771A1 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase
06/02/1999EP0918761A1 Certain amido- and amino-substituted benzylamine derivatives; a new class of neuropeptite y1 specific ligands
06/02/1999EP0918747A1 INHIBITORS OF THE PRODUCTION OF s-CD23 AND THE SECRETION OF TNF
06/02/1999EP0918545A2 Tumour therapy
06/02/1999EP0918534A1 Peptidyl prodrugs and methods of making and using the same
06/02/1999EP0918532A1 A novel method of detecting and treating cancer
06/02/1999EP0918515A2 USE OF INHIBITORS OF THE CELLULAR Na?+ /H?+ EXCHANGER (NHE) FOR PREPARING A MEDICAMENT FOR NORMALIZING SERUM LIPIDS
06/02/1999EP0918514A1 Triaryl methane compounds for sickle cell disease
06/02/1999EP0918504A2 Genistein as a preventive against ultraviolet induced skin photodamage and cancer
06/02/1999EP0918455A1 Galanin
06/02/1999EP0845036B1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
06/02/1999EP0757718A4 Methods of use of uncoated gel particles
06/02/1999EP0691849B1 Oesteoblast growth stimulating compostion containing pdgf and vitamin d
06/02/1999EP0667854B1 Peptidyl activated ketone inhibitors containing natural and unnatural peptide sequences
06/02/1999EP0581939B1 N-sulphonyl-2-oxoindole derivatives having affinity for vasopressin and/or ocytocin receptors
06/02/1999EP0548254B1 6- or 7-(imidazolidin-2-ylideneamino)-1,4-benzoxazines as alpha adrenergic agents
06/02/1999DE19752952A1 Thienopyrimidine Thienopyrimidines
06/02/1999CN1218471A Carboline derivatives
06/02/1999CN1218467A Sulphur derivatives comprising amide bond, method for preparing same, use thereof as drugs, and pharmaceutical compositions containing such derivatives
06/02/1999CN1218464A 2,3 disulbstituted-4 (3H)-quinazolinones
06/02/1999CN1218463A Asymmetric synthesis of R-'alpha'-propyl-piperonyl amine and its analogs
06/02/1999CN1218461A Alkylaminobenzothiazole and -benzoxazole derivatives
06/02/1999CN1218456A Irreversible inhibitors of tyrosine kinases
06/02/1999CN1218410A Use of IL-12 and IFN-'alpha' for treatment of infections diseases
06/02/1999CN1218408A Method of treatment
06/02/1999CN1218406A HLA-A2.1 binding peptides and their uses
06/02/1999CN1218405A Treatment of cystic disease with TNF-'alpha'
06/02/1999CN1218404A HLA binding peptides and their uses
06/02/1999CN1218368A Method for treating common cold or allergic rhinitis
06/02/1999CN1218052A New indole and indazole compounds, process for their preparation and pharmaceutical compositions containing them
06/02/1999CN1218051A New 2,3-dioxide, indanol compounds, process for their preparation and pharmaceutical compositions containing them
06/02/1999CN1218050A Sulfonamide-substituted benzopyran derivates processes for their preparation, their use as medicament, and pharmaceutical preparations comprising them
06/02/1999CN1218049A Chromene derivatives and salts thereof, and pharmaceuticals containing the same
06/02/1999CN1218044A Urea derivatives
06/02/1999CN1218026A Manufacture of tomato metabolite of carotenoid
06/02/1999CN1043532C The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy
06/02/1999CN1043509C Antioxidant cardioprotective use of and method of treatment using, hydroxycarbazole compounds
06/02/1999CA2254949A1 Transgenic animal
06/02/1999CA2223075A1 Drug binding protein
06/01/1999US5908923 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection
06/01/1999US5908863 Geminal carboxylic acids and esters thereof pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism
06/01/1999US5908853 Therapy for sexual disorders
06/01/1999US5908851 Derivatives of succinamide and their use as metalloproteinase inhibitor
06/01/1999US5908849 Anti-oxidant esters of non-steroidal anti-inflammatory agents
06/01/1999US5908843 Thrombosis, antiinflammatory agent, arteriosclerosis, antitumor agents
06/01/1999US5908824 Dispersed homogeneously in and adsorbed homogeneously onto a mucosa protecting and/or tissue repairing agent
06/01/1999CA2056334C Process for producing benzylphthalazinone derivatives and salts thereof
06/01/1999CA1340567C Heterocyclic amide derivatives
05/1999
05/27/1999WO1999025863A1 Transfection and transfer of male germ cells for generation of transgenic species
05/27/1999WO1999025832A1 Toso
05/27/1999WO1999025831A2 Slit polypeptide and method of modulation of robo with ligands
05/27/1999WO1999025830A1 Transcriptionally regulated g protein-coupled receptor
05/27/1999WO1999025720A1 Carbohydrate derivatives
05/27/1999WO1999025714A1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists
05/27/1999WO1999025710A1 Imidazole derivatives, preparation and therapeutic application thereof
05/27/1999WO1999025701A1 NOVEL HETEROCYCLICALLY SUBSTITUTED α-HYDROXYCARBOXLIC ACID DERIVATIVES, METHOD FOR PRODUCING THE SAME AND THEIR USE AS ENDOTHELIN RECEPTOR ANTAGONISTS
05/27/1999WO1999025695A1 5-arylpyrazole compounds
05/27/1999WO1999025690A2 Advanced glycation end-product intermediaries and post-amadori inhibition
05/27/1999WO1999025687A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
05/27/1999WO1999025686A1 Cyclic amine derivatives and their use as drugs
05/27/1999WO1999025374A1 Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders
05/27/1999WO1999025372A1 Small peptides and methods for treatment of asthma and inflammation
05/27/1999WO1999025366A1 Use of cytokines and mitogens to inhibit pathological immune responses
05/27/1999WO1999025356A1 Use of mirtazapine for treating sleep apneas
05/27/1999WO1999025344A1 Use of oxazolidinone derivatives for treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
1 ... 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 ... 1564